What is Gainful?
Gainful operates at the intersection of biotechnology and consumer wellness, providing a highly personalized supplement experience tailored to individual physiology and fitness objectives. By integrating the expertise of Registered Dietitians with rigorous, milligram-level quality control, the company addresses the systemic confusion often associated with the supplement industry. Its platform serves as a digital-first solution for consumers seeking transparency and efficacy, effectively bridging the gap between generic health products and clinical-grade nutritional support. Through its commitment to one-on-one professional consultation, Gainful has established a defensible moat in the direct-to-consumer health market, positioning itself as a critical player in the evolving landscape of personalized preventative care.
How much funding has Gainful raised?
Gainful has raised a total of $7.5M across 1 funding round:
Series A
$7.5M
Series A (2021): $7.5M, investors not publicly disclosed
Key Investors in Gainful
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Gainful?
With the recent infusion of capital, Gainful is well-positioned to accelerate its strategic roadmap, focusing on product diversification and the expansion of its digital health ecosystem. The company is expected to prioritize the integration of advanced biometric data to further refine its personalized formulations, thereby increasing customer retention and lifetime value. Furthermore, the firm will likely explore strategic partnerships with broader wellness platforms to scale its reach. As it navigates this major enterprise-level funding stage, the focus will shift toward operational efficiency and the solidification of its brand as the premier authority in customized nutritional science.
See full Gainful company page
